French Regulator Links Sanofi Epilepsy Drug to Birth Defects

Up to 4,100 children in France suffered major malformations in the womb after their mothers took a treatment against epilepsy and bipolar disorders known as valproate between 1967 and 2016, France’s drug regulator said. Valproate, which has been manufactured in …

from News – Insurance Journal